Insider Transactions in Q4 2023 at Sight Sciences, Inc. (SGHT)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 27
2023
|
D1 Capital Partners L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
2,852,036
-48.74%
|
$14,260,180
$5.86 P/Share
|
|
Nov 30
2023
|
Staffan Encrantz |
BUY
Open market or private purchase
|
Direct |
140,777
+12.21%
|
$422,331
$3.46 P/Share
|
|
Nov 29
2023
|
Staffan Encrantz |
BUY
Open market or private purchase
|
Direct |
3,223
+0.37%
|
$9,669
$3.5 P/Share
|
|
Nov 28
2023
|
Staffan Encrantz |
BUY
Open market or private purchase
|
Direct |
253,669
+22.61%
|
$761,007
$3.46 P/Share
|
|
Nov 27
2023
|
Staffan Encrantz |
BUY
Open market or private purchase
|
Direct |
246,331
+28.62%
|
$738,993
$3.31 P/Share
|
|
Nov 24
2023
|
Staffan Encrantz |
BUY
Open market or private purchase
|
Direct |
21,855
+5.6%
|
$65,565
$3.09 P/Share
|
|
Nov 24
2023
|
David Badawi Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
150,000
+8.42%
|
$0
$0.11 P/Share
|
|
Nov 22
2023
|
Staffan Encrantz |
BUY
Open market or private purchase
|
Direct |
41,085
+10.61%
|
$82,170
$2.5 P/Share
|
|
Nov 21
2023
|
Staffan Encrantz |
BUY
Open market or private purchase
|
Direct |
68,477
+18.32%
|
$136,954
$2.48 P/Share
|
|
Nov 20
2023
|
Staffan Encrantz |
BUY
Open market or private purchase
|
Direct |
79,234
+25.08%
|
$158,468
$2.25 P/Share
|
|
Nov 17
2023
|
Staffan Encrantz |
BUY
Open market or private purchase
|
Direct |
126,664
+44.57%
|
$253,328
$2.19 P/Share
|
|
Nov 16
2023
|
Staffan Encrantz |
BUY
Open market or private purchase
|
Direct |
339
+1.09%
|
$678
$2.0 P/Share
|
|
Nov 14
2023
|
Matthew Link Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
747,572
+50.0%
|
-
|
|
Nov 14
2023
|
Staffan Encrantz |
BUY
Open market or private purchase
|
Direct |
3,462
+10.19%
|
$6,924
$2.0 P/Share
|